IBDEI0P8 ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,12367,1,4,0)
 ;;=4^V15.59
 ;;^UTILITY(U,$J,358.3,12367,2)
 ;;=^336787
 ;;^UTILITY(U,$J,358.3,12368,0)
 ;;=413.9^^69^755^1
 ;;^UTILITY(U,$J,358.3,12368,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12368,1,3,0)
 ;;=3^Angina Pectoris NEC/NOS
 ;;^UTILITY(U,$J,358.3,12368,1,4,0)
 ;;=4^413.9
 ;;^UTILITY(U,$J,358.3,12368,2)
 ;;=^87258
 ;;^UTILITY(U,$J,358.3,12369,0)
 ;;=716.90^^69^755^2
 ;;^UTILITY(U,$J,358.3,12369,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12369,1,3,0)
 ;;=3^Arthropathy NOS
 ;;^UTILITY(U,$J,358.3,12369,1,4,0)
 ;;=4^716.90
 ;;^UTILITY(U,$J,358.3,12369,2)
 ;;=^66343
 ;;^UTILITY(U,$J,358.3,12370,0)
 ;;=428.0^^69^755^3
 ;;^UTILITY(U,$J,358.3,12370,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12370,1,3,0)
 ;;=3^CHF,Unspec
 ;;^UTILITY(U,$J,358.3,12370,1,4,0)
 ;;=4^428.0
 ;;^UTILITY(U,$J,358.3,12370,2)
 ;;=^54758
 ;;^UTILITY(U,$J,358.3,12371,0)
 ;;=585.9^^69^755^4
 ;;^UTILITY(U,$J,358.3,12371,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12371,1,3,0)
 ;;=3^Chr Kidney Disease NOS
 ;;^UTILITY(U,$J,358.3,12371,1,4,0)
 ;;=4^585.9
 ;;^UTILITY(U,$J,358.3,12371,2)
 ;;=^332812
 ;;^UTILITY(U,$J,358.3,12372,0)
 ;;=585.1^^69^755^5
 ;;^UTILITY(U,$J,358.3,12372,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12372,1,3,0)
 ;;=3^Chr Kidney Disease,Stage I
 ;;^UTILITY(U,$J,358.3,12372,1,4,0)
 ;;=4^585.1
 ;;^UTILITY(U,$J,358.3,12372,2)
 ;;=^332807
 ;;^UTILITY(U,$J,358.3,12373,0)
 ;;=585.2^^69^755^6
 ;;^UTILITY(U,$J,358.3,12373,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12373,1,3,0)
 ;;=3^Chr Kidney Disease,Stage II
 ;;^UTILITY(U,$J,358.3,12373,1,4,0)
 ;;=4^585.2
 ;;^UTILITY(U,$J,358.3,12373,2)
 ;;=^332808
 ;;^UTILITY(U,$J,358.3,12374,0)
 ;;=585.3^^69^755^7
 ;;^UTILITY(U,$J,358.3,12374,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12374,1,3,0)
 ;;=3^Chr Kidney Disease,Stage III
 ;;^UTILITY(U,$J,358.3,12374,1,4,0)
 ;;=4^585.3
 ;;^UTILITY(U,$J,358.3,12374,2)
 ;;=^332809
 ;;^UTILITY(U,$J,358.3,12375,0)
 ;;=585.4^^69^755^8
 ;;^UTILITY(U,$J,358.3,12375,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12375,1,3,0)
 ;;=3^Chr Kidney Disease,Stage IV
 ;;^UTILITY(U,$J,358.3,12375,1,4,0)
 ;;=4^585.4
 ;;^UTILITY(U,$J,358.3,12375,2)
 ;;=^332810
 ;;^UTILITY(U,$J,358.3,12376,0)
 ;;=585.5^^69^755^9
 ;;^UTILITY(U,$J,358.3,12376,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12376,1,3,0)
 ;;=3^Chr Kidney Disease,Stage V
 ;;^UTILITY(U,$J,358.3,12376,1,4,0)
 ;;=4^585.5
 ;;^UTILITY(U,$J,358.3,12376,2)
 ;;=^332811
 ;;^UTILITY(U,$J,358.3,12377,0)
 ;;=585.6^^69^755^11
 ;;^UTILITY(U,$J,358.3,12377,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12377,1,3,0)
 ;;=3^ESRD
 ;;^UTILITY(U,$J,358.3,12377,1,4,0)
 ;;=4^585.6
 ;;^UTILITY(U,$J,358.3,12377,2)
 ;;=^303986
 ;;^UTILITY(U,$J,358.3,12378,0)
 ;;=401.9^^69^755^12
 ;;^UTILITY(U,$J,358.3,12378,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12378,1,3,0)
 ;;=3^Hypertension
 ;;^UTILITY(U,$J,358.3,12378,1,4,0)
 ;;=4^401.9
 ;;^UTILITY(U,$J,358.3,12378,2)
 ;;=^186630
 ;;^UTILITY(U,$J,358.3,12379,0)
 ;;=250.01^^69^755^10
 ;;^UTILITY(U,$J,358.3,12379,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12379,1,3,0)
 ;;=3^DM Type I w/o Complications
 ;;^UTILITY(U,$J,358.3,12379,1,4,0)
 ;;=4^250.01
 ;;^UTILITY(U,$J,358.3,12379,2)
 ;;=^331780
 ;;^UTILITY(U,$J,358.3,12380,0)
 ;;=907.0^^69^755^14
 ;;^UTILITY(U,$J,358.3,12380,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12380,1,3,0)
 ;;=3^Lt Eff Intracranial Inj
 ;;^UTILITY(U,$J,358.3,12380,1,4,0)
 ;;=4^907.0
 ;;^UTILITY(U,$J,358.3,12380,2)
 ;;=^68489
 ;;^UTILITY(U,$J,358.3,12381,0)
 ;;=438.9^^69^755^13
 ;;^UTILITY(U,$J,358.3,12381,1,0)
 ;;=^358.31IA^4^2
